Literature DB >> 2071393

Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effects of nicardipine.

P Puig-Parellada1, J M Planas, J Giménez, J Sánchez, J Gaya, E Tolosa, J Obach.   

Abstract

The levels of Prostacyclin (PGI2) and Thromboxane A2 (TXA2) were assayed simultaneously (RIA) in the plasma and saliva of 9 patients suffering from classical migraine attacks. The assays were done during an attack-free period. In relation to the control group we observed a significant decrease in the plasma levels of PGI2 together with a sharp increase in TXA2 in saliva. When the patients were treated with nicardipine, a calcium antagonist, the TXA2 increase in saliva did not occur. These results suggest both a systemic and local effect in the classical migraine attacks. We explain and discuss our results by referring to the PGI2: TXA2 equilibrium system. Nicardipine action might be related to its ability to reduce the calcium entry into the cell induced by thromboxane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071393     DOI: 10.1111/j.1526-4610.1991.hed3103156.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?

Authors:  J A Zeller; K Frahm; R Baron; R Stingele; G Deuschl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

2.  Monocyte chemotactic and phagocytic responses in migraine and tension-type headache patients.

Authors:  V Gallai; P Sarchielli; A Trequattrini; M Paciaroni
Journal:  Ital J Neurol Sci       Date:  1993-03

3.  Expression of prostaglandin I2 (prostacyclin) receptor in blood of migraine patients: A potential biomarker.

Authors:  Majid Kheirollahi; Mohammad Kazemi; Gilda Amini; Fariborz Khorvash; Fatemeh Ahangari; Mahsa Kolahdouz; Leila Koulivand
Journal:  Adv Biomed Res       Date:  2015-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.